Ras is also an important factor in many cancers where it is not mutated but rather functionally activated through inappropriate activity of other signal transduction elements, for example, by overexpressed growth factor receptors in breast cancer [17, 18] or by loss of a GAP, such as in type 1 neurofibromatosis (NF1) [19]. Here, NF1 is linked to cancer.